Haemato-oncology is one of Liverpool’s recognised strengths with scientific expertise in Chronic Myeloid Leukemia (CML) and lymphoproliferative disorders and strong clinical leadership that includes chairmanship of the National Cancer Research Institute (NCRI) Haematological Oncology CSG and CML Subgroup and membership of the Lymphoma CSG and Subgroups for Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), High Grade Non-Hodgkin's Lymphomas (HG-NHL) and Low Grade Non-Hodgkin's Lymphomas (LG-NHL).